These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34454284)

  • 1. Application of T cell receptor (TCR) repertoire analysis for the advancement of cancer immunotherapy.
    Joshi K; Milighetti M; Chain BM
    Curr Opin Immunol; 2022 Feb; 74():1-8. PubMed ID: 34454284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-throughput sequencing of the immune repertoire in oncology: Applications for clinical diagnosis, monitoring, and immunotherapies.
    Ye B; Smerin D; Gao Q; Kang C; Xiong X
    Cancer Lett; 2018 Mar; 416():42-56. PubMed ID: 29247824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell repertoire analysis and metrics of diversity and clonality.
    Chiffelle J; Genolet R; Perez MA; Coukos G; Zoete V; Harari A
    Curr Opin Biotechnol; 2020 Oct; 65():284-295. PubMed ID: 32889231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell repertoire diversity: friend or foe for protective antitumor response?
    Porciello N; Franzese O; D'Ambrosio L; Palermo B; Nisticò P
    J Exp Clin Cancer Res; 2022 Dec; 41(1):356. PubMed ID: 36550555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of TCR repertoire patterns linked with anti-cancer immunotherapy.
    Vandoren R; Gielis S; Laukens K; Meysman P
    Methods Cell Biol; 2024; 183():115-142. PubMed ID: 38548409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3D: diversity, dynamics, differential testing - a proposed pipeline for analysis of next-generation sequencing T cell repertoire data.
    Zhang L; Cham J; Paciorek A; Trager J; Sheikh N; Fong L
    BMC Bioinformatics; 2017 Feb; 18(1):129. PubMed ID: 28241742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of TCR Repertoire Associated With Successful Immune Checkpoint Therapy Responses.
    Kidman J; Principe N; Watson M; Lassmann T; Holt RA; Nowak AK; Lesterhuis WJ; Lake RA; Chee J
    Front Immunol; 2020; 11():587014. PubMed ID: 33163002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-Cell Receptor Repertoire Sequencing in the Era of Cancer Immunotherapy.
    Frank ML; Lu K; Erdogan C; Han Y; Hu J; Wang T; Heymach JV; Zhang J; Reuben A
    Clin Cancer Res; 2023 Mar; 29(6):994-1008. PubMed ID: 36413126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell receptor-based cancer immunotherapy: Emerging efficacy and pathways of resistance.
    Chandran SS; Klebanoff CA
    Immunol Rev; 2019 Jul; 290(1):127-147. PubMed ID: 31355495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TCR sequencing and cloning methods for repertoire analysis and isolation of tumor-reactive TCRs.
    Genolet R; Bobisse S; Chiffelle J; Arnaud M; Petremand R; Queiroz L; Michel A; Reichenbach P; Cesbron J; Auger A; Baumgaertner P; Guillaume P; Schmidt J; Irving M; Kandalaft LE; Speiser DE; Coukos G; Harari A
    Cell Rep Methods; 2023 Apr; 3(4):100459. PubMed ID: 37159666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell receptor repertoire analysis for the diagnosis and treatment of solid tumor: A methodology and clinical applications.
    Li N; Yuan J; Tian W; Meng L; Liu Y
    Cancer Commun (Lond); 2020 Oct; 40(10):473-483. PubMed ID: 32677768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TCR repertoires of intratumoral T-cell subsets.
    Linnemann C; Mezzadra R; Schumacher TN
    Immunol Rev; 2014 Jan; 257(1):72-82. PubMed ID: 24329790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging Strategies in TCR-Engineered T Cells.
    Wei F; Cheng XX; Xue JZ; Xue SA
    Front Immunol; 2022; 13():850358. PubMed ID: 35432319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular T-Cell Repertoire Analysis as Source of Prognostic and Predictive Biomarkers for Checkpoint Blockade Immunotherapy.
    Aversa I; Malanga D; Fiume G; Palmieri C
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural high-avidity T-cell receptor efficiently mediates regression of cancer/testis antigen 83 positive common solid cancers.
    Li Q; Hu W; Liao B; Song C; Li L
    J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35798537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal distribution and intratumour heterogeneity of the B-cell repertoire in oesophageal squamous cell carcinoma.
    Zhang C; Huang H; Miao Y; Xiong H; Lu Z
    J Pathol; 2018 Nov; 246(3):323-330. PubMed ID: 30027584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TCR Convergence in Individuals Treated With Immune Checkpoint Inhibition for Cancer.
    Looney TJ; Topacio-Hall D; Lowman G; Conroy J; Morrison C; Oh D; Fong L; Zhang L
    Front Immunol; 2019; 10():2985. PubMed ID: 31993050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PD-L1 Checkpoint Inhibition Narrows the Antigen-Specific T Cell Receptor Repertoire in Chronic Lymphocytic Choriomeningitis Virus Infection.
    Klein S; Ghersi D; Manns MP; Prinz I; Cornberg M; Kraft ARM
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T Cell Receptor Chain Centricity: The Phenomenon and Potential Applications in Cancer Immunotherapy.
    Kalinina AA; Khromykh LM; Kazansky DB
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rigorous benchmarking of T-cell receptor repertoire profiling methods for cancer RNA sequencing.
    Peng K; Nowicki TS; Campbell K; Vahed M; Peng D; Meng Y; Nagareddy A; Huang YN; Karlsberg A; Miller Z; Brito J; Nadel B; Pak VM; Abedalthagafi MS; Burkhardt AM; Alachkar H; Ribas A; Mangul S
    Brief Bioinform; 2023 Jul; 24(4):. PubMed ID: 37291798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.